Trial intelligence / Profile preview

Melatonin for Appetite in Advanced Cancer

NCT00513357Phase 3Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
Jun 2006
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in gastrointestinal cancer, lung cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2006; status: completed.

02

Drugs

melatonin
03

Conditions

gastrointestinal cancerlung cancer

Beyond the preview

Go deeper on NCT00513357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00513357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call